Mengye He

439 total citations
24 papers, 327 citations indexed

About

Mengye He is a scholar working on Oncology, Molecular Biology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Mengye He has authored 24 papers receiving a total of 327 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Oncology, 7 papers in Molecular Biology and 4 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Mengye He's work include Autophagy in Disease and Therapy (3 papers), Cholangiocarcinoma and Gallbladder Cancer Studies (3 papers) and Radiomics and Machine Learning in Medical Imaging (2 papers). Mengye He is often cited by papers focused on Autophagy in Disease and Therapy (3 papers), Cholangiocarcinoma and Gallbladder Cancer Studies (3 papers) and Radiomics and Machine Learning in Medical Imaging (2 papers). Mengye He collaborates with scholars based in China. Mengye He's co-authors include Qingqing Wang, Peng Shen, Aijuan Wang, Shusen Zheng, Peng Shen, Jian Ruan, Ming Chen, Qi Jiang, Xing‐Can Shen and Hua Chen and has published in prestigious journals such as Journal of Clinical Oncology, Nano Letters and Analytical Chemistry.

In The Last Decade

Mengye He

22 papers receiving 325 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mengye He China 10 106 97 73 64 42 24 327
Beibei Zhai China 11 276 2.6× 195 2.0× 37 0.5× 35 0.5× 76 1.8× 24 517
Jindian Li China 14 136 1.3× 96 1.0× 54 0.7× 55 0.9× 134 3.2× 33 487
Sandrine Pacquelet France 12 133 1.3× 62 0.6× 39 0.5× 96 1.5× 26 0.6× 18 423
Junyi Han China 10 209 2.0× 151 1.6× 32 0.4× 78 1.2× 61 1.5× 19 513
N Yu Lukianova Ukraine 11 184 1.7× 148 1.5× 61 0.8× 53 0.8× 55 1.3× 66 447
Kathrin Heinzmann United Kingdom 9 93 0.9× 59 0.6× 41 0.6× 23 0.4× 95 2.3× 16 317
Wanhua Lin China 8 152 1.4× 68 0.7× 26 0.4× 22 0.3× 46 1.1× 11 337
Jian Qin China 11 219 2.1× 52 0.5× 60 0.8× 49 0.8× 20 0.5× 21 442
Hanning Li China 15 210 2.0× 69 0.7× 85 1.2× 42 0.7× 9 0.2× 31 397

Countries citing papers authored by Mengye He

Since Specialization
Citations

This map shows the geographic impact of Mengye He's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mengye He with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mengye He more than expected).

Fields of papers citing papers by Mengye He

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mengye He. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mengye He. The network helps show where Mengye He may publish in the future.

Co-authorship network of co-authors of Mengye He

This figure shows the co-authorship network connecting the top 25 collaborators of Mengye He. A scholar is included among the top collaborators of Mengye He based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mengye He. Mengye He is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
He, Mengye, et al.. (2026). Application of surface-enhanced Raman spectroscopy in the diagnosis and treatment of breast cancer. Frontiers in Medicine. 12. 1725221–1725221.
2.
3.
4.
Jia, Yuming, Junli Wang, Xiao Luo, et al.. (2025). Predictive nomogram integrating radiomics and multi‐omics for improved prognosis‐model in cholangiocarcinoma. Clinical and Translational Medicine. 15(1). e70171–e70171. 2 indexed citations
5.
Jia, Yunlu, Yongxia Chen, Ming Chen, et al.. (2024). Oncogenic HJURP enhancer promotes the aggressive behavior of triple-negative breast cancer in association with p53/E2F1/FOXM1-axis. Cancer Letters. 611. 217423–217423. 2 indexed citations
6.
He, Mengye, et al.. (2024). Mitochondria/lysosome dual-organelle labelling esterase probe for monitoring cell viability and evaluating lung cancer drug efficiency. Spectrochimica Acta Part A Molecular and Biomolecular Spectroscopy. 327. 125379–125379. 3 indexed citations
7.
Wang, Liping, Mengye He, Xingyue Liu, et al.. (2024). Dual-Labeled Single Fluorescent Probes for the Simultaneous Two-Color Visualization of Dual Organelles and for Monitoring Cell Autophagy. Analytical Chemistry. 96(2). 876–886. 15 indexed citations
8.
Yuan, Ye, Mengye He, Liping Wang, Xing‐Can Shen, & Hua Chen. (2023). Unexpected dual-functional cyanine fluorophores: NIR multifunctional fluorescent probes for simultaneous monitoring of mitochondrial cysteine /viscosity during kidney ferroptosis in vivo. Sensors and Actuators B Chemical. 396. 134600–134600. 28 indexed citations
9.
Chen, Yongxia, Mengye He, Yina Wang, et al.. (2023). Clinical and molecular profiling of EGFR-mutant lung adenocarcinomas transformation to small cell lung cancer during TKI treatment. Frontiers in Oncology. 13. 1308313–1308313. 4 indexed citations
10.
He, Mengye, et al.. (2023). Fatty Acid Metabolism: A New Perspective in Breast Cancer Precision Therapy. Frontiers in Bioscience-Landmark. 28(12). 348–348. 10 indexed citations
11.
He, Mengye, et al.. (2022). Long survival after immunotherapy plus paclitaxel in advanced intrahepatic cholangiocarcinoma: A case report and review of literature. World Journal of Clinical Cases. 10(32). 11889–11897. 4 indexed citations
12.
Zhang, Xiao‐Chen, et al.. (2022). Alpha-fetoprotein-producing hepatoid adenocarcinoma of the lung responsive to sorafenib after multiline treatment: A case report. World Journal of Clinical Cases. 10(28). 10236–10243. 4 indexed citations
13.
Chen, Ming, Mengye He, Zhenhao Li, et al.. (2022). Sporoderm-Broken Spores of Ganoderma lucidum Sensitizes Ovarian Cancer to Cisplatin by ROS/ERK Signaling and Attenuates Chemotherapy-Related Toxicity. Frontiers in Pharmacology. 13. 826716–826716. 16 indexed citations
14.
15.
Yan, Feifei, Qi Jiang, Mengye He, & Peng Shen. (2021). Parp Inhibitor Treatment of Advanced Breast Cancer Beyond the BRCA -Mutated Type: A Meta-Analysis. Future Oncology. 17(18). 2381–2393. 6 indexed citations
16.
Wang, Luo, et al.. (2021). HER2 changes to positive after neoadjuvant chemotherapy in breast cancer: A case report and literature review. World Journal of Clinical Cases. 10(1). 260–267. 2 indexed citations
17.
Xie, Mixue, Mengye He, Feifei Yan, et al.. (2019). PITX2 methylation: a novel and effective biomarker for monitoring biochemical recurrence risk of prostate cancer. Medicine. 98(1). e13820–e13820. 7 indexed citations
18.
Chen, Ming, Pu Liu, Feifei Yan, et al.. (2018). Distinctive features of immunostaining and mutational load in primary pulmonary enteric adenocarcinoma: implications for differential diagnosis and immunotherapy. Journal of Translational Medicine. 16(1). 81–81. 36 indexed citations
19.
Shen, Peng, Ming Chen, Mengye He, et al.. (2016). Inhibition of ERα/ERK/P62 cascades induces “autophagic switch” in the estrogen receptor-positive breast cancer cells exposed to gemcitabine. Oncotarget. 7(30). 48501–48516. 21 indexed citations
20.
Chen, Ming, Mengye He, Yinjing Song, et al.. (2014). The cytoprotective role of gemcitabine-induced autophagy associated with apoptosis inhibition in triple-negative MDA-MB-231 breast cancer cells. International Journal of Molecular Medicine. 34(1). 276–282. 25 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Beibei Zhai Breakdown of academic impact, for papers by Jindian Li Breakdown of academic impact, for papers by Sandrine Pacquelet Breakdown of academic impact, for papers by Junyi Han Breakdown of academic impact, for papers by N Yu Lukianova Breakdown of academic impact, for papers by Kathrin Heinzmann Breakdown of academic impact, for papers by Wanhua Lin Breakdown of academic impact, for papers by Jian Qin Breakdown of academic impact, for papers by Hanning Li
Rankless by CCL
2026